Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF

PloS One
Sylvain GarciazJulie di Cristofaro

Abstract

We studied a cohort of 367 healthy related donors who volunteered to donate their hematopoietic stem cells for allogeneic transplantation. All donors were homogeneously cared for at a single institution, and received rhG-CSF as a mobilization treatment prior to undergoing apheresis. Peripheral blood CD34+ cell counts were used as the main surrogate marker for rhG-CSF induced mobilization. We searched whether inter-individual variations in known genetic polymorphisms located in genes whose products are functionally important for mobilization, could affect the extent of CD34+ mobilization, either individually or in combination. We found little or no influence of individual SNPs or haplotypes for the SDF1, CXCR4, VCAM and VLA4 genes, whether using CD34+ cell counts as a continuous or a categorical variable. Simple clinical characteristics describing donors such as body mass index, age and possibly sex are more potent predictors of stem cell mobilization. The size of our cohort remains relatively small for genetic analyses, however compares favorably with cohorts analyzed in previously published reports suggesting associations of genetic traits to response to rhG-CSF; notwithstanding this limitation, our data do not support the use...Continue Reading

References

Jan 5, 2000·The Journal of Clinical Investigation·D Y JoM A Moore
Dec 6, 2000·The Journal of Clinical Investigation·T PonomaryovT Lapidot
May 18, 2012·Current Drug Metabolism·Hsueh-Wei ChangCheng-Hong Yang
Jul 31, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Juliane LenkChristian Thiede
Jun 4, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Johan TörlénMary Eapen
May 23, 2015·Drug Metabolism Reviews·Renu ChaudharyAnil K Chhillar
Feb 27, 2016·Evolutionary Bioinformatics Online·José Manuel Nunes
Oct 5, 2016·PloS One·Federico CarliniJulie Di Cristofaro
Nov 15, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Seiji MishimaAtsushi Nagai

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
leukapheresis
flow-cytometry
PCR
electrophoresis

Software Mentioned

Phenotype
Codon Code Aligner
GeneMapper
R
Gene [ rate ]
SPSS
Gene
Gene [ ]
random
forest SRC package

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.